$WW

Sjoqvist Nikolaj H purchased $100K of WW

Sjoqvist Nikolaj H purchased 7,235 shares of WW INTERNATIONAL, INC. (WW) at $13.84 ($0.10M total) on 2026-08-18.

Original reporting
SEC EDGAR · Sjoqvist Nikolaj H
Published Aug 20, 2026, 8:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 8:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$WW
Neutral
medium confidence
Mentioned
$WW
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$WWNeutralLow
01

Why it matters

The purchase adds to insider buying activity but is not material enough to drive price.

02

Market read

Minor insider purchase; limited trading relevance.

03

What to watch

Potential upcoming share repurchase program or strategic partnership not yet announced.

Relevance 5/10Novelty 5/10Timing: filing date 2026-08-20

Background

Form 4 filings disclose insider transactions; investors monitor them for signals.

Company-level read

Ticker impact

$WWNeutralMedium confidence
Context

Director Sjoqvist Nikolaj H purchased 7,235 shares of WW for $100K via open-market transaction.

Expected impact

minimal upward pressure, likely negligible

Evidence & confidence

Purchase size is modest relative to float; typical insider buys have low immediate effect.

Market effects

None significant for consumer services sector.

No regional effect.

Limited to WW shareholders.

Counterpoint

Insider purchase could be a strategic move ahead of undisclosed corporate action.

Key entities

  • WW International, Inc.

    Publicly traded consumer services company (ticker WW).

  • Sjoqvist Nikolaj H

    Director of WW International.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$WWHigh

Why is WW International stock rallying today?

WW International's stock rose 8.6% after Northland Securities initiated coverage with an Outperform rating and $25.00 price target, citing partnerships and long-term recovery potential. Institutional investors increased positions, and the broader market's tech growth theme supported the rally.

$WWHigh

Wall Street eyes WW International recovery following bullish Northland initiation

WW International (WW) shares rose 8% after Northland initiated coverage with an Outperform rating and $25 target. The firm cited WW's turnaround strategy and partnerships as key to recovery. WW faced challenges from GLP-1 medications and debt, leading to a bankruptcy filing in May 2025. Analysts highlight strategic collaborations with Google, Eli Lilly, and Sam's Club as potential growth drivers.

$WWHigh

Why WeightWatchers (WW) Shares Are Falling Today

WeightWatchers (WW) shares fell 10.3% due to declining demand for traditional diet programs amid rising use of GLP-1 weight-loss drugs. The drop follows a previous 6.4% decline, despite a partnership with Google Health Enterprise. WW stock is down 56.1% YTD, trading at $13.80, 60.5% below its 52-week high.

$WWHigh

WeightWatchers (WW) Stock Trades Up, Here Is Why

WeightWatchers (WW) stock rose 8.9% premarket after announcing a partnership with Google Health to integrate wearable tech and AI into its wellness programs. Eligible members will receive Fitbit devices and health services upon meeting activity goals. WW is down 44.4% YTD, trading at $17.49, 49.9% below its 52-week high. The company appointed Stephen Bye as CEO, effective this fall, to drive growth and transformation.

$WWHigh

Why is WW International stock surging today?

WW International stock rose 10.4% in pre-market trading after announcing a collaboration with Google Health Enterprise, integrating Google's wearable tech with Weight Watchers' wellness programs. The partnership targets the corporate health benefits market and follows a technical breakout above the 200-day moving average. Institutional investors have increased their stakes, with Cygnus Capital Advisors doubling its position and Bank of New York Mellon initiating a new stake.